IP Library Granted Patent US 12,544,212
Granted Patent B2
US 12,544,212 · App. 17/611,668 · Granted Feb 10, 2026

Aortic pressure loss reduction apparatus and methods

Inventors: Sagy Karavany (Kibbutz Dvir, IL); Menashe Yacoby (Shoham, IL); Tanhum Feld (Moshav Merhavya, IL)
Assignee: HEMODYNAMX-TECHNOLOGIES LTD
A61F2/06A61F2/07A61F2/915A61F2002/068A61F2002/8486A61F2002/91525A61F2002/91541A61F2002/91575A61F2220/0075A61F2230/001A61F2230/0067A61F2230/0078A61F2250/001A61F2250/0039
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,544,212
App. No.
17/611,668
Granted
Feb 10, 2026
Kind
B2
Abstract

Apparatus and methods are described including an aortic pressure-loss-reduction device (20) configured to be implanted inside an ascending aorta of a subject. The aortic pressure-loss-reduction device includes a frame (52) that defines an upstream anchor portion (33F), an intermediate portion (23F) configured to define a conduit (26) therethrough, and a downstream anchor portion (31F). Angled struts (150) are disposed between a downstream end of the upstream anchor portion (33F) and an upstream end of the intermediate portion (23F). The angled struts (150) are configured such that, in response to a diameter of the upstream anchor portion (33F) changing by an absolute amount, an absolute change in a diameter of the upstream end of the intermediate portion (23F) is less than the absolute amount by which the diameter of the upstream anchor portion (33F) changes. Other applications are also described.

Claims (69)

1 . Apparatus comprising:

an aortic pressure-loss-reduction device configured to be implanted inside an ascending aorta of a subject, the aortic pressure-loss-reduction device comprising:

a frame that is configured, in a non-constrained configuration thereof, to define:

an upstream anchor portion configured to radially expand against an inner wall of the subject's ascending aorta, such as to anchor an upstream end of the aortic pressure-loss-reduction device to the subject's ascending aorta;

an intermediate portion configured to define a conduit therethrough, such that blood is configured to flow through the device via the conduit, at least a portion of the conduit diverging, such that a downstream end of the diverging portion has a greater cross-sectional area than an upstream end of the diverging portion;

a downstream anchor portion configured to radially expand against the inner wall of the subject's ascending aorta, such as to anchor a downstream end of the aortic pressure-loss-reduction device to the subject's ascending aorta;

a first set of angled struts disposed between a downstream end of the upstream anchor portion and an upstream end of the intermediate portion, the angled struts being shaped to form a folded portion between the downstream end of the upstream anchor portion and the upstream end of the intermediate portion;

the angled struts being configured such that, in response to a diameter of the upstream anchor portion changing by an absolute amount, an absolute change in a diameter of the upstream end of the intermediate portion is less than the absolute amount by which the diameter of the upstream anchor portion changes; and

a material layer coupled to at least a portion of the frame, the material layer configured to impede blood flow therethrough,

wherein, in the non-constrained configuration of the frame, the angled struts define a circumferential curvature with respect to a longitudinal axis of the frame.

2 . The apparatus according to claim 1 , wherein the angled struts define a sinusoidal curvature.

3 . The apparatus according to claim 1 , wherein the angled struts are configured such that a ratio of the absolute change in the diameter of the upstream end of the intermediate portion to the absolute amount by which the diameter of the upstream anchor portion changes is less than 1:2.

4 . The apparatus according to claim 1 , wherein the angled struts are configured such that in response to the diameter of the upstream anchor portion decreasing, the diameter of the upstream end of the intermediate portion increases.

5 . The apparatus according to claim 1 , wherein the material layer is coupled to an outside of at least a portion of the frame.

6 . The apparatus according to claim 1 , wherein the material layer is coupled to an inside of at least a portion of the frame.

7 . The apparatus according to claim 1 , wherein at least a portion of the frame is embedded within the material layer.

8 . The apparatus according to claim 1 , wherein the angled struts are configured such that, when the frame is in the non-radially-constrained configuration, a distance from an upstream end of the upstream anchor portion to the upstream end of the intermediate portion is less than 15 mm.

9 . The apparatus according to claim 1 , wherein the angled struts are configured such that, when the frame is in the non-radially-constrained configuration, an upstream end of the conduit extends beyond an upstream end of the upstream anchor portion in the upstream direction.

10 . The apparatus according to claim 1 , wherein the angled struts are configured such that, in response to the diameter of the upstream anchor portion decreasing, the circumferential curvature of the struts with respect to the longitudinal axis of the frame increases.

11 . The apparatus according to claim 1 , wherein the angled struts are configured such that, by virtue of an increase in the circumferential curvature of the struts with respect to longitudinal axis of the frame, the difference between the diameter of the upstream end of the intermediate portion and the diameter of the upstream anchor portion decreases.

12 . Apparatus comprising:

an aortic pressure-loss-reduction device configured to be implanted inside an ascending aorta of a subject, the aortic pressure-loss-reduction device comprising:

a frame that is configured, in a non-constrained configuration thereof, to define:

an upstream anchor portion configured to radially expand against an inner wall of the subject's ascending aorta, such as to anchor an upstream end of the aortic pressure-loss-reduction device to the subject's ascending aorta;

an intermediate portion configured to define a conduit therethrough, such that blood is configured to flow through the device via the conduit, at least a portion of the conduit diverging, such that a downstream end of the diverging portion has a greater cross-sectional area than an upstream end of the diverging portion;

a downstream anchor portion configured to radially expand against the inner wall of the subject's ascending aorta, such as to anchor a downstream end of the aortic pressure-loss-reduction device to the subject's ascending aorta;

a first set of angled struts disposed between a downstream end of the upstream anchor portion and an upstream end of the intermediate portion, the angled struts being shaped to form a folded portion between the downstream end of the upstream anchor portion and the upstream end of the intermediate portion;

the angled struts being configured such that, in response to a diameter of the upstream anchor portion changing by an absolute amount, an absolute change in a diameter of the upstream end of the intermediate portion is less than the absolute amount by which the diameter of the upstream anchor portion changes; and

a material layer coupled to at least a portion of the frame, the material layer configured to impede blood flow therethrough,

wherein the upstream end of the intermediate portion is reinforced with respect to at least a longitudinally-central portion of the intermediate portion.

13 . The apparatus according to claim 12 , wherein the upstream end of the intermediate portion and the longitudinally-central portion of the intermediate portion comprise a first set of struts, and wherein the upstream end of the intermediate portion is reinforced with respect to at least the longitudinally-central portion of the intermediate portion by the first set of struts of the upstream end of the intermediate portion being reinforced with supporting struts that face in an opposite direction from the first set of struts of the upstream end of the intermediate portion.

14 . The apparatus according to claim 12 , wherein the upstream end of the intermediate portion and the longitudinally-central portion of the intermediate portion comprise struts, and wherein the upstream end of the intermediate portion is reinforced with respect to at least the longitudinally-central portion of the intermediate portion by the struts of the upstream end of the intermediate portion forming closed cells.

15 . The apparatus according to claim 12 , wherein the upstream end of the intermediate portion and the longitudinally-central portion of the intermediate portion comprise struts, and wherein the upstream end of the intermediate portion is reinforced with respect to at least the longitudinally-central portion of the intermediate portion by the struts of the upstream end of the intermediate portion being shorter than the struts of the longitudinally-central portion of the intermediate portion.

16 . The apparatus according to claim 12 , wherein the upstream end of the intermediate portion and the longitudinally-central portion of the intermediate portion comprise struts, and wherein the upstream end of the intermediate portion is reinforced with respect to at least the longitudinally-central portion of the intermediate portion by the struts of the upstream end of the intermediate portion being wider than the struts of the longitudinally-central portion of the intermediate portion.

17 . Apparatus comprising:

an aortic pressure-loss-reduction device configured to be implanted inside an ascending aorta of a subject, the aortic pressure-loss-reduction device comprising:

a frame that is configured, in a non-constrained configuration thereof, to define:

an upstream anchor portion configured to radially expand against an inner wall of the subject's ascending aorta, such as to anchor an upstream end of the aortic pressure-loss-reduction device to the subject's ascending aorta;

an intermediate portion configured to define a conduit therethrough, such that blood is configured to flow through the device via the conduit, at least a portion of the conduit diverging, such that a downstream end of the diverging portion has a greater cross-sectional area than an upstream end of the diverging portion;

a downstream anchor portion configured to radially expand against the inner wall of the subject's ascending aorta, such as to anchor a downstream end of the aortic pressure-loss-reduction device to the subject's ascending aorta;

a first set of angled struts disposed between a downstream end of the upstream anchor portion and an upstream end of the intermediate portion, the angled struts being shaped to form a folded portion between the downstream end of the upstream anchor portion and the upstream end of the intermediate portion;

the angled struts being configured such that, in response to a diameter of the upstream anchor portion changing by an absolute amount, an absolute change in a diameter of the upstream end of the intermediate portion is less than the absolute amount by which the diameter of the upstream anchor portion changes;

a material layer coupled to at least a portion of the frame, the material layer configured to impede blood flow therethrough; and

a second set of angled struts disposed between an upstream end of the downstream anchor portion and a downstream end of the intermediate portion, the second set of angled struts being shaped to form a folded portion between the upstream end of the downstream anchor portion and the downstream end of the intermediate portion.

18 . The apparatus according to claim 17 , wherein, in the non-constrained configuration of the frame, the first set of angled struts define a circumferential curvature with respect to a longitudinal axis of the frame in a given circumferential direction, and the second set of angled struts define a circumferential curvature with respect to the longitudinal axis of the frame in the given circumferential direction.

19 . The apparatus according to claim 17 , wherein the second set of angled struts are configured such that, in response to a diameter of the downstream anchor portion changing by an absolute amount, an absolute change in a diameter of the downstream end of the intermediate portion is less than the absolute amount by which the diameter of the downstream anchor portion changes.

20 . The apparatus according to claim 17 , wherein the second set of angled struts are configured such that, in response to diameters of both the upstream and the downstream anchor portions decreasing, torque that is generated at the upstream end of the intermediate portion, by the first set of angled struts, is at least partially cancelled by torque generated at the downstream end of the intermediate portion, by the second set of angled struts.

21 . The apparatus according to claim 17 , wherein the aortic pressure-loss-reduction device is configured, such that the intermediate portion of the device is (a) longitudinally fixed with respect to the ascending aorta by the upstream anchor portion and the downstream anchor portion exerting radial force against the inner wall of the aorta and (b) able to adjust the angle that a longitudinal axis of the intermediate portion makes with longitudinal axes of the upstream and downstream anchor portions, by the first and second sets of angled struts acting as hinges about which the intermediate portion can flex.

22 . The apparatus according to claim 17 , wherein the aortic pressure-loss-reduction device is configured such that, by virtue of flexibility of first and second sets of angled struts, a length of the intermediate portion does not change even if a distance between the upstream and downstream anchor portions changes.

23 . The apparatus according to claim 17 , wherein the struts belonging to the first set of angled struts are longer than the struts belonging to the second set of angled struts.

24 . Apparatus comprising:

an aortic pressure-loss-reduction device configured to be implanted inside an ascending aorta of a subject, the aortic pressure-loss-reduction device comprising:

a frame that is configured, in a non-constrained configuration thereof, to define:

an upstream anchor portion configured to radially expand against an inner wall of the subject's ascending aorta, such as to anchor an upstream end of the aortic pressure-loss-reduction device to the subject's ascending aorta;

an intermediate portion configured to define a conduit therethrough, such that blood is configured to flow through the device via the conduit, at least a portion of the conduit diverging, such that a downstream end of the diverging portion has a greater cross-sectional area than an upstream end of the diverging portion;

a downstream anchor portion configured to radially expand against the inner wall of the subject's ascending aorta, such as to anchor a downstream end of the aortic pressure-loss-reduction device to the subject's ascending aorta;

a first set of angled struts disposed between a downstream end of the upstream anchor portion and an upstream end of the intermediate portion, the angled struts being shaped to form a folded portion between the downstream end of the upstream anchor portion and the upstream end of the intermediate portion;

the angled struts being configured such that, in response to a diameter of the upstream anchor portion changing by an absolute amount, an absolute change in a diameter of the upstream end of the intermediate portion is less than the absolute amount by which the diameter of the upstream anchor portion changes; and

a material layer coupled to at least a portion of the frame, the material layer configured to impede blood flow therethrough,

wherein the intermediate portion of the frame is configured to be flexible, by the intermediate portion of the frame including struts that form a spiral, such that at least upon the aortic pressure-loss-reduction device being implanted inside the subject's ascending aorta, the intermediate portion of the frame curves such as to conform with a curvature of the ascending aorta.

25 . Apparatus comprising:

an aortic pressure-loss-reduction device configured to be implanted inside an ascending aorta of a subject, the aortic pressure-loss-reduction device comprising:

a frame that is configured, in a non-constrained configuration thereof, to define:

an upstream anchor portion configured to radially expand against an inner wall of the subject's ascending aorta, such as to anchor an upstream end of the aortic pressure-loss-reduction device to the subject's ascending aorta;

an intermediate portion configured to define a conduit therethrough, such that blood is configured to flow through the device via the conduit, at least a portion of the conduit diverging, such that a downstream end of the diverging portion has a greater cross-sectional area than an upstream end of the diverging portion;

a downstream anchor portion configured to radially expand against the inner wall of the subject's ascending aorta, such as to anchor a downstream end of the aortic pressure-loss-reduction device to the subject's ascending aorta;

a first piece of material coupled to the frame, the first piece of material configured to impede blood flow therethrough; and

a second piece of material coupled to the frame, the second piece of material configured to impede blood flow therethrough,

the second piece of material being stitched to the first piece of material at a longitudinal location that varies around a circumference of the device when the device is disposed in a radially-constrained configuration.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2025
From: HEMODYNAMX TECHNOLOGIES LTD.
To: HEMODYNAMX LTD.
Reel/Frame 069909/0283 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2021
From: KARAVANY, SAGY; YACOBY, MENASHE; FELD, TANHUM
To: HEMODYNAMX-TECHNOLOGIES LTD.
Reel/Frame 058147/0236 →
Continuity (2)
Provisional Application 62850656 · May 21, 2019
Related Publication 20220241063A1 · Aug 4, 2022
References Cited (130)
US 5139515A · Robicsek · 1992 [cited by applicant]
US 6120534A · Ruiz · 2000 [cited by applicant]
US 7018404B2 · Holmberg et al. · 2006 [cited by applicant]
US 7429269B2 · Schwammenthal et al. · 2008 [cited by applicant]
US 7766814B2 · Walsh · 2010 [cited by applicant]
US 8585572B2 · Mehmanesh · 2013 [cited by applicant]
US 8623065B2 · Lau et al. · 2014 [cited by applicant]
US 8715337B2 · Chuter · 2014 [cited by applicant]
US 9232992B2 · Heidner et al. · 2016 [cited by applicant]
US 10368985B2 · Wilson et al. · 2019 [cited by applicant]
US 10568731B2 · Karavany et al. · 2020 [cited by applicant]
US 11207200B2 · Karavany · 2021 [cited by examiner]
US 11224503B2 · Karavany et al. · 2022 [cited by applicant]
US 20030045828A1 · Wilk · 2003 [cited by applicant]
US 20040093058A1 · Cottone et al. · 2004 [cited by applicant]
US 20040249439A1 · Richter et al. · 2004 [cited by applicant]
US 20040260389A1 · Case et al. · 2004 [cited by applicant]
US 20050055082A1 · Ben Muvhar · 2005 [cited by examiner]
US 20050222674A1 · Paine · 2005 [cited by applicant]
US 20050228480A1 · Douglas · 2005 [cited by examiner]
US 20060009835A1 · Osborne et al. · 2006 [cited by applicant]
US 20060106449A1 · Ben · 2006 [cited by applicant]
US 20060149360A1 · Schwammenthal et al. · 2006 [cited by applicant]
US 20060178552A1 · Gross · 2006 [cited by applicant]
US 20060259134A1 · Schwammenthal et al. · 2006 [cited by applicant]
US 20060271171A1 · Mcquinn et al. · 2006 [cited by applicant]
US 20070185565A1 · Schwammenthal et al. · 2007 [cited by applicant]
US 20070293808A1 · Williams et al. · 2007 [cited by applicant]
US 20080071361A1 · Tuval et al. · 2008 [cited by applicant]
US 20080071363A1 · Tuval et al. · 2008 [cited by applicant]
US 20090105805A1 · Baker et al. · 2009 [cited by applicant]
US 20090198315A1 · Boudjemline · 2009 [cited by applicant]
US 20090210047A1 · Amplatz et al. · 2009 [cited by applicant]
US 20090222078A1 · Greenberg · 2009 [cited by applicant]
US 20090240320A1 · Tuval et al. · 2009 [cited by applicant]
US 20090270965A1 · Sinha et al. · 2009 [cited by applicant]
US 20100023046A1 · Heidner et al. · 2010 [cited by applicant]
US 20100145433A1 · Anukhin et al. · 2010 [cited by applicant]
US 20110288634A1 · Tuval et al. · 2011 [cited by applicant]
US 20120010690A1 · Richter et al. · 2012 [cited by applicant]
US 20120022629A1 · Perera et al. · 2012 [cited by applicant]
US 20130013053A1 · Hartley et al. · 2013 [cited by applicant]
US 20130144383A1 · Thill et al. · 2013 [cited by applicant]
US 20130178750A1 · Sheehan et al. · 2013 [cited by applicant]
US 20140121757A1 · Debruyne · 2014 [cited by examiner]
US 20140222142A1 · Kovalsky · 2014 [cited by examiner]
US 20140257474A1 · Roeder · 2014 [cited by applicant]
US 20150238315A1 · Rabito et al. · 2015 [cited by applicant]
US 20150366693A1 · Kagan et al. · 2015 [cited by applicant]
US 20170042551A1 · Celermajer et al. · 2017 [cited by applicant]
US 20170340460A1 · Rosen · 2017 [cited by applicant]
US 20180036109A1 · Karavany et al. · 2018 [cited by applicant]
US 20180353281A1 · Nussinovitch · 2018 [cited by applicant]
US 20190183629A1 · Karavany · 2019 [cited by examiner]
US 20210169634A1 · Karavany et al. · 2021 [cited by applicant]
US 20220071788A1 · Karavany et al. · 2022 [cited by applicant]
CN 101287424A · 2008 [cited by applicant]
EP 1849440A1 · 2007 [cited by applicant]
EP 2016961B1 · 2010 [cited by applicant]
EP 2777618A1 · 2014 [cited by applicant]
EP 2896387A1 · 2015 [cited by applicant]
EP 2785277B1 · 2017 [cited by applicant]
JP 2001527453A · 2001 [cited by applicant]
JP 2007526789A · 2007 [cited by applicant]
JP 2008537891A · 2008 [cited by applicant]
JP 2011502628A · 2011 [cited by applicant]
WO 9852476A1 · 1998 [cited by applicant]
WO 03028522A2 · 2003 [cited by applicant]
WO 2005002466A2 · 2005 [cited by applicant]
WO 2005084730A1 · 2005 [cited by applicant]
WO 2006070372A2 · 2006 [cited by applicant]
WO 2006080010A2 · 2006 [cited by applicant]
WO 2009061419A1 · 2009 [cited by applicant]
WO 2012018590A1 · 2012 [cited by applicant]
WO 2015013344A2 · 2015 [cited by applicant]
WO 2016128983A1 · 2016 [cited by applicant]
WO 2018029688A1 · 2018 [cited by applicant]
WO 2018220589A1 · 2018 [cited by applicant]
WO 2019097424A2 · 2019 [cited by applicant]
WO 2020234787A1 · 2020 [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/526,053 mailed Jan. 12, 2023. [cited by applicant]
Communication Pursuant to Article 94(3) EPC for European Patent Application No. 16748842.8 mailed Jun. 17, 2022. [cited by applicant]
Examination Report for European Application No. 16748842.8 mailed Jun. 17, 2022. [cited by applicant]
First Action Interview Pilot Program Pre-Interview Communication for U.S. Appl. No. 16/743,721 mailed Dec. 3, 2021. [cited by applicant]
Issue Notification for U.S. Appl. No. 16/322,047 mailed Dec. 28, 2021. [cited by applicant]
Issue Notification for U.S. Appl. No. 16/763,884 mailed Dec. 8, 2021. [cited by applicant]
Issue Notification for U.S. Appl. No. 16/743,721 mailed May 25, 2022. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/743,721 mailed Feb. 22, 2022. [cited by applicant]
Hearing Notice for Indian Application No. 201717029373 mailed Jan. 18, 2024. [cited by applicant]
Issue Notification for U.S. Appl. No. 17/526,053 mailed Dec. 20, 2023. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/526,053 mailed Aug. 30, 2023. [cited by applicant]
European Search Report for European Application No. 16748842.8 mailed Sep. 19, 2018. [cited by applicant]
Examination Report for Indian Application No. 201717029373 mailed Oct. 8, 2020. [cited by applicant]
Extended European Search Report for European Application No. 18878693.3 mailed Jul. 8, 2021. [cited by applicant]
Final Office Action for U.S. Appl. No. 15/550,661 mailed Jun. 19, 2019. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IB2018/058961 mailed May 8, 2019. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IB2020/054761 mailed Oct. 28, 2020. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IL2016/050170 mailed Jun. 10, 2016. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IL2017/050884 mailed Oct. 30, 2017. [cited by applicant]
Issue Notification for U.S. Appl. No. 15/550,661 mailed Feb. 5, 2020. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 15/550,661 mailed Aug. 6, 2019. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 15/550,661 mailed Feb. 20, 2019. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/322,047 mailed Mar. 3, 2021. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 15/550,661 mailed Oct. 17, 2019. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/322,047 mailed Sep. 14, 2021. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/763,884 mailed Aug. 16, 2021. [cited by applicant]
Office Action for Chinese Application No. 201680015323.5 mailed Dec. 14, 2018. [cited by applicant]
Office Action for Chinese Application No. 201780049360.2 mailed May 25, 2021. [cited by applicant]
Office Action for Chinese Application No. 201780049360.2 mailed Oct. 10, 2020. [cited by applicant]
Office Action for Chinese Application No. 201910988467.4 mailed May 24, 2021. [cited by applicant]
Office Action for Japanese Application No. 2017-542883 mailed Dec. 10, 2019. [cited by applicant]
Protege webpage—downloaded Mar. 19, 2015. [cited by applicant]
Restriction Requirement for U.S. Appl. No. 15/550,661 mailed Dec. 4, 2018. [cited by applicant]
Restriction Requirement for U.S. Appl. No. 16/743,721 mailed Sep. 1, 2021. [cited by applicant]
Supplemental Notice of Allowability for U.S. Appl. No. 15/550,661 mailed Jan. 23, 2020. [cited by applicant]
U.S. Appl. No. 15/550,661, filed Aug. 11, 2017. [cited by applicant]
U.S. Appl. No. 16/322,047, filed Jan. 30, 2019. [cited by applicant]
U.S. Appl. No. 16/743,721, filed Jan. 15, 2020. [cited by applicant]
U.S. Appl. No. 16/763,884, filed May 13, 2020. [cited by applicant]
U.S. Appl. No. 17/526,053, filed Nov. 15, 2021. [cited by applicant]
U.S. Appl. No. 62/115,207, filed Feb. 12, 2015. [cited by applicant]
U.S. Appl. No. 62/265,571, filed Dec. 10, 2015. [cited by applicant]
U.S. Appl. No. 62/373,993, filed Aug. 12, 2016. [cited by applicant]
U.S. Appl. No. 62/586,258, filed Nov. 15, 2017. [cited by applicant]
U.S. Appl. No. 62/630,406, filed Feb. 14, 2018. [cited by applicant]
U.S. Appl. No. 62/850,656, filed May 21, 2019. [cited by applicant]
Heinrich, et al., “Experimental analysis of fluid mechanical energy losses in aortic valve stenosis: importance of pressure recovery”, Annals of biomedical engineering, 1996, pp. 685-694. [cited by applicant]
Examination Report for European Application No. 17755260.1 mailed Jun. 1, 2023. [cited by applicant]
Office Action for Chinese Application No. 201880086395.8 mailed Jan. 18, 2023. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/520,223 mailed Apr. 16, 2025. [cited by applicant]